{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:44:59Z","timestamp":1787237099061,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.ijrobp.2010.01.016","type":"journal-article","created":{"date-parts":[[2010,6,4]],"date-time":"2010-06-04T04:35:34Z","timestamp":1275626134000},"page":"85-90","source":"Crossref","is-referenced-by-count":33,"title":["Dosimetric Impact of Interfraction Catheter Movement in High-Dose Rate Prostate Brachytherapy"],"prefix":"10.1016","volume":"80","author":[{"given":"William","family":"Foster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Adam M.","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.-Chow","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivan","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devan","family":"Krishnamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Pouliot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2010.01.016_bib1","unstructured":"National Comprehensive Cancer Network. Clinical practice guidelines in oncology: Prostate cancer. Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/prostate.pdf."},{"key":"10.1016\/j.ijrobp.2010.01.016_bib2","doi-asserted-by":"crossref","first-page":"097","DOI":"10.1016\/S0360-3016(02)02829-8","article-title":"Prostate cancer radiation dose response: Results of the M.D. Anderson phase III randomized trial","volume":"53","author":"Pollack","year":"2002","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.01.016_bib3","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1200\/JCO.2000.18.14.2740","article-title":"Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the Radiation Therapy Oncology Group trials","volume":"18","author":"Valicenti","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.01.016_bib4","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/jjco\/hyn056","article-title":"Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone","volume":"38","author":"Fang","year":"2008","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.01.016_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1200\/jco.2009.27.15_suppl.5118","article-title":"Dose escalation with high-dose 3D-conformal radiotherapy (HD-3D-CRT) or low-dose 3D-conformal radiotherapy plus HDR brachytherapy (LD-3D-CRT + HDR-B) for intermediate- or high-risk prostate cancer: Early results of a prospective comparative trial","volume":"27","author":"Guix","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.01.016_bib6","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0360-3016(03)00131-7","article-title":"Analysis of interaction between number of implant catheters and dose-volume-histograms in prostate high-dose-rate brachytherapy using a computer model","volume":"56","author":"Charra-Brunaud","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.01.016_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0167-8140(03)00203-2","article-title":"High dose rate afterloading brachytherapy for prostate cancer: Catheter and gland movement between fractions","volume":"68","author":"Hoskin","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2010.01.016_bib8","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.ijrobp.2003.08.020","article-title":"Analysis of serial CT Scans to assess template and catheter movement in prostate HDR brachytherapy","volume":"58","author":"Mullokandov","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.01.016_bib9","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0360-3016(99)00477-0","article-title":"Needle displacement during HDR brachytherapy in the treatment of prostate cancer","volume":"46","author":"Damore","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.01.016_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0360-3016(00)01463-2","article-title":"Phase II prospective study of the use of conformal High-Dose Rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report","volume":"49","author":"Martinez","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.01.016_bib11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.radonc.2009.09.015","article-title":"Justification for inter-fraction correction of catheter movement in fractionated high dose-rate brachytherapy treatment of prostate cancer","volume":"93","author":"Simnor","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2010.01.016_bib12","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1118\/1.1368127","article-title":"Inverse planning anatomy-based dose optimization for HDR-brachytherapy of the prostate using fast simulated annealing algorithm and dedicated objective function","volume":"28","author":"Lessard","year":"2001","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2010.01.016_bib13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0167-8140(98)00021-8","article-title":"Intra- and inter-observer variability in contouring prostate and seminal vesicles: Implications for conformal treatment planning","volume":"47","author":"Fiorino","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2010.01.016_bib14","author":"Hsu","year":"2008","journal-title":"Boston, MA"},{"key":"10.1016\/j.ijrobp.2010.01.016_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.radonc.2005.10.003","article-title":"Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer: A phase II study","volume":"78","author":"Pinkawa","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2010.01.016_bib16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.7150\/ijms.5.113","article-title":"The relationship between the biochemical control outcomes and the quality of planning of high-dose rate brachytherapy as a boost to external beam radiotherapy for locally and locally advanced prostate cancer using the RTOG-ASTRO Phoenix definition","volume":"5","author":"Pellizzon","year":"2008","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.ijrobp.2010.01.016_bib17","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ijrobp.2008.05.003","article-title":"An eight-year experience of HDR brachytherapy boost for localized prostate cancer: Biopsy and PSA outcome","volume":"73","author":"Bachand","year":"2009","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.01.016_bib18","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.radonc.2005.04.002","article-title":"Anatomy-based inverse planning dose optimization in HDR prostate implant: A toxicity study","volume":"75","author":"Mahmoudieh","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2010.01.016_bib19","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.brachy.2005.03.005","article-title":"Combined modality treatment with high-dose-rate brachytherapy boost for locally advanced prostate cancer","volume":"4","author":"Hsu","year":"2005","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2010.01.016_bib20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.brachy.2009.03.019","article-title":"High-dose-rate prostate brachytherapy and supplemental external beam radiotherapy: A comparison of single fraction 15Gy high-dose-rate and hypofractionated external beam to a conventional fractionated regimen","volume":"8","author":"Morton","year":"2009","journal-title":"Brachytherapy"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161000115X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161000115X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T18:30:18Z","timestamp":1635445818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030161000115X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S036030161000115X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2010.01.016","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}